REDX-05358
CAS No. 1884226-20-3
REDX-05358( REDX 05358 | REDX05358 )
Catalog No. M12942 CAS No. 1884226-20-3
REDX-05358 is a novel potent, highly selective, orally bioavailable pan RAF inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 873 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameREDX-05358
-
NoteResearch use only, not for human use.
-
Brief DescriptionREDX-05358 is a novel potent, highly selective, orally bioavailable pan RAF inhibitor.
-
DescriptionREDX-05358 is a novel potent, highly selective, orally bioavailable pan RAF inhibitor with IC50 of 0.1, 0.68, 0.171, and 0.076 nM for ARAF, BRAF, BRAF (V600E), and CRAF, respectively; denmonstrates high selectivity profile against a panel of 468 kinases, exhibits negligible paradoxical activation due to inhibition of both RAF monomers and dimers; not only inhibits MAPK signalling in BRAF V600E mutant tumor cells, but also in those harbouring NRAS and KRAS mutations; exhibits in vivo efficacy in BRAF V600E CRC xenograft model.
-
In Vitro——
-
In Vivo——
-
SynonymsREDX 05358 | REDX05358
-
PathwayMAPK/ERK Signaling
-
TargetRaf
-
RecptorRaf
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1884226-20-3
-
Formula Weight472.929
-
Molecular FormulaC26H21ClN4O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?H2O : < 0.1 mg/mL (insoluble))
-
SMILESO=C(CC1)NC2=C1C(OC3=CC(CC(C4=NC=C(C5=CC=CC=C5Cl)N4)CO6)=C6C=C3)=CC=N2
-
Chemical Name5-[[3-[5-(2-Chlorophenyl)-1H-imidazol-2-yl]chroman-6-yl]oxy]-3,4-dihydro-1H-1,8-naphthyridin-2-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Helen Mason, et al. AACR, Abstract 5160.
molnova catalog
related products
-
GDC-0349
GDC-0349 is a potent and selective ATP-competitive inhibitor of mTOR with Ki of 3.8 nM, 790-fold inhibitory effect against PI3Kα and other 266 kinases. Phase 1.
-
I-49 free base
I-49 is a novel benzylamino substituted pyridopyrimidinone as SOS1 inhibitor.
-
Dabrafenib Mesylate
Dabrafenib Mesylate is a B-Raf inhibitor(IC50s of 0.6 and 5.0 nM for RafV600E and c-Raf, respectively).
Cart
sales@molnova.com